Last updated on February 2018

Treatment for Eczema (commonly known as Atopic Dermatitis)

Brief description of study

A Prospective, vehicle-controlled, double blind, multicenter, randomized phase II study of B244 delivered as a topical spray to determine safety in subjects with mild to moderate atopic dermatitis.

Clinical Study Identifier: TX155618

Contact Investigators or Research Sites near you

Start Over

Selika Gutierrez Borst, MS, RN

DeNova Research
Chicago, IL USA
  Connect »